SB1677 is a bill that, upon FDA approval of midomafetamine (MDMA) for the treatment of PTSD by December 31, 2025, would authorize workers' compensation coverage to include one complete course of MDMA treatment for firefighters and certified peace officers diagnosed with PTSD, provided certain conditions are met. The bill outlines the requirements for workers' compensation coverage, stipulates that MDMA must meet controlled substance requirements, and mandates that the Industrial Commission of Arizona (ICA) submit an annual report on the costs of MDMA treatment to the Joint Legislative Budget Committee starting January 1, 2026.

The bill defines relevant terms, including "certified peace officer," "firefighter," "licensed mental health professional," "psychiatrist," and "treatment protocol of Midomafetamine." It also specifies that the enactment of this legislation is contingent on the FDA's approval of MDMA for PTSD treatment by the specified date. If the condition is met, the Department of Health Services must notify the Arizona Legislative Council and the ICA, after which the ICA is required to assign reimbursement values and publish billing guidelines for MDMA.

Statutes affected:
Introduced Version: 23-972
Senate Engrossed Version: 23-972, 38-674, 38-842
House Engrossed Version: 23-972
Chaptered Version: 23-972